EMA — authorised 16 November 2011
- Status: approved
🇪🇺 Vyndaqel in European Union
EMA authorised Vyndaqel on 16 November 2011
Marketing authorisation
Vyndaqel in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in European Union
Frequently asked questions
Is Vyndaqel approved in European Union?
Yes. EMA authorised it on 16 November 2011.
Who is the marketing authorisation holder for Vyndaqel in European Union?
Foldrx Pharms is the originator. The local marketing authorisation holder may differ — check the official source linked above.